The PowdAir Plus is a new capsule-based dry powder inhaler that has an innovative, discreet, and patented design.
H&T Presspart specialises in the development of custom drug delivery components made from metal or plastic.
Optimising products from concept to delivery, the company studies and refines its processes to ensure optimum performance and quality.
Metered-dose inhaler (MDI) canisters and actuators
H&T Presspart has more than 45 years’ experience of supplying metal metered-dose-inhalers (MDI), which are produced using the deep drawing method. The company offers a complete range of canisters including 10ml, 14ml, 17ml, and 19ml capacities designed for full compatibility with the actuator, valve, and drug formulation of the MDI.
H&T Presspart’s canister portfolio is suitable for use with hydrofluoroalkane (HFA) and chlorofluorocarbon (CFC) propellants.
As one of the leading suppliers of MDI components, H&T Presspart produces a comprehensive range of MDI actuators, which are made from a wide range of plastic resins. One or two piece actuators are available for both solution and suspension formulations. Key features include tight dimensional tolerances, a reliable manufacturing process, and the ability to withstand extreme temperatures.
Plasma surface treatment technology for MDI canisters
H&T Presspart’s sub-micron plasma surface treatment improves the surface energy performance of an MDI canister. This helps prevent deposition of active drug content on the canister wall to improve dosing efficiency and enhance drug stability performance, which ultimately helps extend shelf life and reduce product degradation.
Connected smart MDIs
Launched in partnership with Cohero Health, H&T Presspart’s fully-connected electronic metered-dose inhaler (eMDI) is designed to improve adherence and optimise care for patients with asthma and chronic obstructive pulmonary disease (COPD). It incorporates Cohero Health’s BreatheSmart management platform, which provides tracking of controller and rescue medications, as well as real-time, clinically accurate lung function measurement.
Easy-to-use capsule based dry powder inhaler
H&T Presspart’s PowdAir Plus is a four-component, capsule-based dry powder inhaler (DPI), which is designed to be discreet. This easy-to-use device provides an accurate dose delivery in a simple and low-cost method.
The patented capsule is compact and portable. This simple and innovative DPI helps reduce manufacturing assembly and production costs, while maintaining a sleek and aesthetical design.
History of H&T Presspart
Since 1970, H&T Presspart has provided DPI devices from its manufacturing sites in Germany, the UK, and Spain. This is supported by effective sales offices in India, China, the US, and South America. In addition, the firm has been established as a leading partner to many of the world’s largest pharmaceutical companies worldwide.
H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the technology for pipeline development and value-added product differentiation.
In this article, H&T Presspart's programme manager Benjamin Jung and US sales and business development director Dana Shears describe the role of connected devices in the treatment of asthma and COPD. They discuss the requirements for mass adoption and introduce their inhaler, the eDMI, which has connectivity fully enabled.
Hydrofluoroalkane (HFA) based propellants are widely used in modern metered-dose inhalers (MDI) due to their lack of hazardous and environmentally damaging effects.
Devices for delivering drugs to the lungs have evolved considerably over the past few decades.
Contract Manufacturing (CMO) has long been associated with the global pharmaceutical industry, primarily as outsourcing providers of finished medicines.
Respiratory disorders affect hundreds of millions of people worldwide, with an estimated 300 million people suffering from asthma and a further 210 million with chronic obstructive pulmonary disease (COPD).
H&T Presspart had announced it will be presenting its components for respiratory drug delivery systems at this year’s Digitalization in Pharma Summit.
A collaboration between H&T Presspart and Cohero Health has yielded the world's first connected inhaler for tracking and improving medication adherence, eMDI.
H&T Presspart have announced the opening of a new sales office to cover the Latin America region.
Heitkamp & Thumann Group's Presspart has appeared on the market, wearing its new logo.
Presspart, a division of the Heitkamp & Thumann Group and the world's leading provider of specialist metal and plastic components to the pharmaceutical industry, are pleased to announce the appointment of Ameet Sule to the position of Director of Inhalation Product Technology Centre (IPTC), effective from 15 January 2013.
Presspart Manufacturing Releases New White Paper: ‘Modifying MDI Canister Surfaces to Improve Drug Stability and Drug Delivery’
Presspart Manufacturing, a specialist in the field of bespoke metal and plastic drug delivery components and devices, has released a new white paper entitled 'Modifying MDI Canister Surfaces to Improve Drug Stability and Drug Delivery'. Over the past few years, a number of surface coat
Presspart, a division of the Heitkamp & Thumann Group, has launched a new sub-micron plasma process for coating and treating the internal surfaces of pMDI canisters. Presspart plasma coating and Presspart plasma treatment offer solutions for problems with deposition of drug suspension on the
Presspart Manufacturing Releases New White Paper: ‘Optimising Metered Dose Inhalers for Respiratory Disorders’
Presspart Manufacturing specialises in high-precision metal and plastic components and drug delivery devices for the pharmaceutical and healthcare industry. In particular, Presspart is a leader in the field of metal MDI canisters, MDI valve components, plastic actuators and new drug delivery dev
Presspart Nemo, the new specialist injection moulding division of Presspart, has begun manufacturing a six-piece nasal drug delivery device for GlaxoSmithKline's Avamys (fluticasone furoate), an intranasal corticosteroid treatment for allergic rhinitis. Presspart is the world's leading
Presspart, a division of the Heitkamp & Thumann Group, has been invited to present at the Chinese SFDA training seminar in Shanghai, on 28-29 October 2009. The seminar will focus on the importance of quality control and regulations during filling and production of pressurised metered dose
Presspart, the world's leading provider of specialist metal components to the pharmaceutical industry, is expanding its product offerings with a new range of plastic drug delivery components. The company will be exhibiting these for the first time at Pharmapack 2009 in Paris, 21-22 January, on st
Blackburn-based Presspart Manufacturing Ltd, the world’s leading provider of specialist metal components to the pharmaceutical industry, today announced it has acquired Nemo, a Spanish-based provider of plastic components to the pharmaceutical and medical industry. The acquisition is an important